CFO Marc Bregman resigns effective April 29, 2022; search underway

ELITE PHARMACEUTICALS INC /NV/

Marc Bregman notified his resignation as CFO, Treasurer, Secretary, and Principal Financial and Accounting Officer.
His last day with the company will be April 29, 2022; he leaves to pursue another opportunity.
The company has commenced a search for a replacement; no successor has been named.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Marc Bregman

Chief Financial Officer, Treasurer and Secretary

ELTP · ELITE PHARMACEUTICALS INC /NV/

Effective: 2022-04-29
Filed: April 18, 2022, 7:59 PM ET

On April 14, 2022, Marc Bregman notified Elite Pharmaceuticals, Inc. (the “Company”) of his intent to leave the Company and resign from his position as Chief Financial Officer, Treasurer and Secretary to pursue another opportunity.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Marc Bregman resigned as Chief Financial Officer, Treasurer and Secretary at ELITE PHARMACEUTICALS INC /NV/.

Action: resigned
Role: Chief Financial Officer, Treasurer and Secretary

Exact text from the filing

On April 14, 2022, Marc Bregman notified Elite Pharmaceuticals, Inc. (the “Company”) of his intent to leave the Company and resign from his position as Chief Financial Officer, Treasurer and Secretary to pursue another opportunity.

View on SEC.gov

ELITE PHARMACEUTICALS INC /NV/ filing history →

Source: SEC EDGAR

accession 0001493152-22-010231

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.